COVID-19 therapy: corticosteroids including dexamethasone and hydrocortisone

Document first published:
Page updated:
Publication type:

In accordance with World Health Organization (WHO) recommendations, this letter explains that systemic corticosteroids should be used in patients with severe and critical COVID-19 disease, but not in patients with non-severe COVID-19.


This letter is co-signed by:

  • NHS National Medical Director, Professor Stephen Powis
  • Chief Pharmaceutical Officer, Dr Keith Ridge CBE